R. Horowski

1.8k total citations
70 papers, 1.2k citations indexed

About

R. Horowski is a scholar working on Neurology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R. Horowski has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R. Horowski's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Plant and fungal interactions (11 papers) and Neurological disorders and treatments (11 papers). R. Horowski is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Plant and fungal interactions (11 papers) and Neurological disorders and treatments (11 papers). R. Horowski collaborates with scholars based in Germany, Italy and United Kingdom. R. Horowski's co-authors include H. Wachtel, Klaus-Jürgen Gräf, Heinz H. Pertz, Sven Jähnichen, R. Dorow, F. Neumann, Francisco Grandas, José Á. Obeso, María Trinidad Herrero and R. J. McDonald and has published in prestigious journals such as Nature, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

R. Horowski

70 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Horowski Germany 19 437 365 232 213 103 70 1.2k
R. Markstein Switzerland 22 927 2.1× 238 0.7× 78 0.3× 778 3.7× 35 0.3× 62 1.5k
E. Stefanini Italy 19 752 1.7× 108 0.3× 96 0.4× 534 2.5× 7 0.1× 37 1.2k
Silvana Tesei Italy 17 292 0.7× 946 2.6× 274 1.2× 126 0.6× 5 0.0× 24 1.6k
M.J. Perren United Kingdom 19 388 0.9× 94 0.3× 45 0.2× 366 1.7× 12 0.1× 29 1.4k
Mitsutoshi Yamamoto Japan 28 705 1.6× 1.4k 3.9× 45 0.2× 445 2.1× 7 0.1× 69 2.1k
M.K. Shellenberger United States 12 503 1.2× 121 0.3× 34 0.1× 252 1.2× 9 0.1× 18 1.1k
David Swope United States 18 313 0.7× 573 1.6× 32 0.1× 194 0.9× 4 0.0× 25 1.2k
Katalin Horváth Hungary 17 271 0.6× 56 0.2× 95 0.4× 231 1.1× 4 0.0× 44 862
Van Nueten Jm 17 234 0.5× 81 0.2× 31 0.1× 207 1.0× 8 0.1× 36 837
John M. Bertoni United States 19 333 0.8× 777 2.1× 46 0.2× 269 1.3× 3 0.0× 67 1.4k

Countries citing papers authored by R. Horowski

Since Specialization
Citations

This map shows the geographic impact of R. Horowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Horowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Horowski more than expected).

Fields of papers citing papers by R. Horowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Horowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Horowski. The network helps show where R. Horowski may publish in the future.

Co-authorship network of co-authors of R. Horowski

This figure shows the co-authorship network connecting the top 25 collaborators of R. Horowski. A scholar is included among the top collaborators of R. Horowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Horowski. R. Horowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riederer, Peter & R. Horowski. (2023). L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin. Journal of Neural Transmission. 130(11). 1323–1335. 7 indexed citations
2.
Horowski, R. & P.-A. Löschmann. (2019). Classical dopamine agonists. Journal of Neural Transmission. 126(4). 449–454. 11 indexed citations
3.
Hübner, Harald, Peter Gmeiner, R. Horowski, et al.. (2007). Characterization of the Molecular Fragment That Is Responsible for Agonism of Pergolide at Serotonin 5-Hydroxytryptamine2B and 5-Hydroxytryptamine2A Receptors. Journal of Pharmacology and Experimental Therapeutics. 324(3). 1136–1145. 16 indexed citations
4.
Jähnichen, Sven, et al.. (2007). Pharmacological properties of a wide array of ergolines at functional alpha1-adrenoceptor subtypes. Naunyn-Schmiedeberg s Archives of Pharmacology. 376(5). 321–330. 20 indexed citations
5.
6.
Dorow, R., et al.. (2006). Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties. Clinical Neuropharmacology. 29(2). 80–86. 77 indexed citations
7.
8.
Jähnichen, Sven, R. Horowski, & Heinz H. Pertz. (2005). Agonism at 5-HT2B receptors is not a class effect of the ergolines. European Journal of Pharmacology. 513(3). 225–228. 77 indexed citations
9.
Woitalla, Dirk, et al.. (2004). Transdermal lisuride delivery in the treatment of Parkinson’s disease. Journal of neural transmission. Supplementum. 89–95. 26 indexed citations
10.
Horowski, R., Heike Beneš, & Kjell Fuxé. (2004). Striatal plasticity and motor learning—importance of circadian rhythms, sleep stages and dreaming…. Parkinsonism & Related Disorders. 10(5). 315–317. 7 indexed citations
11.
Horowski, R.. (2002). Multiple sclerosis and interferon β-1b, past, present and future. Clinical Neurology and Neurosurgery. 104(3). 259–264. 5 indexed citations
12.
Obeso, José Á., Francisco Grandas, María Trinidad Herrero, & R. Horowski. (1994). REVIEW. European Journal of Neuroscience. 6(6). 889–897. 60 indexed citations
13.
Lange, Klaus W., E. Sofić, Matthias Burg, et al.. (1993). The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(6). 586–592. 72 indexed citations
14.
Lange, Klaus W., Peter‐A. Löschmann, H. Wachtel, et al.. (1992). Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. European Journal of Pharmacology. 212(2-3). 247–252. 13 indexed citations
15.
Lange, Klaus W., P.-A. Löschmann, E. Sofić, et al.. (1992). Protection by CPP from MPTP-induced neurodegeneration in marmosets. Neurochemistry International. 21. D17–D17. 1 indexed citations
16.
Wüster, Christian, et al.. (1990). Tergurid bei Hyperprolaktinämie — Erfahrungen bei 5 Patienten. Journal of Molecular Medicine. 68(7). 384–387. 1 indexed citations
17.
Horowski, R., C. D. Marsden, & J. A. Obeso. (1988). Continuous dopaminergic stimulation: state of the art and outlook. PubMed. 27. 249–252. 15 indexed citations
18.
Horowski, R., et al.. (1986). Possible role of gonadal hormones as triggering factors in migraine.. PubMed. 1(4). 405–14. 5 indexed citations
19.
Stracke, H., et al.. (1986). Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.. PubMed. 36(12). 1834–6. 5 indexed citations
20.
Horowski, R.. (1983). Influence of ergot derivatives on prolactin secretion in rats. Mechanisms of action and clinical implications. Cephalalgia. 3(1_suppl). 130–138. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Markstein Breakdown of academic impact, for papers by E. Stefanini Breakdown of academic impact, for papers by Silvana Tesei Breakdown of academic impact, for papers by M.J. Perren Breakdown of academic impact, for papers by Mitsutoshi Yamamoto Breakdown of academic impact, for papers by M.K. Shellenberger Breakdown of academic impact, for papers by David Swope Breakdown of academic impact, for papers by Katalin Horváth Breakdown of academic impact, for papers by Van Nueten Jm Breakdown of academic impact, for papers by John M. Bertoni
Rankless by CCL
2026